In the starfish Marthasterias glacialis, polyethylene glycol (PEG) homologous fused pairs consisting of two imnature oocytes, blocked at the germinal vesicle stage, or two ootids, blocked at the female pronucleus stage, remain arrested at these specific stages, unless they are stimulated by the hormone 1-methyladenine. In contrast, heterologous pairs develop up to female pronucleus formation in the immature partner, indicating that maturation-promoting factor was formed under these conditions. Kinetics for this process, reconstitution of the nuclear envelopes after first polar body extrusion, and delaying effect ofemetine argue for the existence of a true metabolic cooperation process requiring complementary factors present in each partner. The effect of inhibitors that penetrate the plasma membrane points to the possible involvement of endogenous proteases that may activate latent or neosynthesized maturation-promoting factor precursor and/or protein kinases.
starfish, maturation proceeds up to second polar body extrusion and formation of the female pronucleus; in amphibians, a second block occurs in metaphase 2, which is only released upon fertilization or activation.
Heterologous transfer and cell fusion experiments showed that MPF was devoid of specificity (7) (8) (9) and controlled G,-M transition in both somatic and germ cells. Thus, MPF activity, which is destroyed at fertilization, soon reappears and undergoes cycles during early cleavage in amphibians (5, 6, 10) , starfish (8) , and sea urchins (11) . Meiosis reinitiation is triggered by extracts prepared from somatic mammalian cells in late G2-M phase (8, 12, 13) or cdc mutants of yeast (14) . MPF also cycles with the meiotic divisions in Xenopus (6) and the starfish (15) , showing a very low activity during polar body emission. In the starfish, MPF activity completely disappears at the time of the second meiotic cleavage, 110 min after hormone addition (16) , whereas it remains present in the metaphase 2-blocked Xenopus oocyte, due to the presence of a stabilizing cytostatic factor (17) (18) (19) .
Analysis of the conditions required for obtaining partially purified and stabilized preparations of MPF suggests that this factor may correspond to a phosphorylating enzyme system (20) (21) (22) (23) (24) (25) . Moreover, a burst of phosphorylation of oocyte proteins occurs before GVBD during maturation of the starfish (26) (27) (28) (29) , the echiurid Urechis (30) , the polychaete Sabellaria (31), the mollusc Patella (unpublished data), the amphibians Rana and Xenopus (20) (21) (22) (23) (24) (25) (32) (33) (34) , and mammals (35, 36) . In addition, a good correlation has been observed between the cycles of protein phosphorylation and MPF activity during early cleavage of the sea urchin (11) , starfish oocyte maturation (15) , and the somatic mammalian cell cycle (37, 38) . Moreover, unsuccessful attempts have been made to separate the phosphorylation burst and GVBD (27) , an event that may be favored and even triggered by phosphate inhibitors (39) (40) (41) and is repressed following alkaline or protein phosphatase injection (41, 42) . Recently, however, it has been shown that the cyclic inactivation of MPF occurring during starfish meiotic cleavage does not involve a change in the turnover of already bound phosphate but, rather, the proteolytic destruction of a cAMP-independent protein kinase (16) . As already established for Xenopus (6) , the second burst of MPF activity following first meiotic cleavage seems to require new protein synthesis.
The mechanisms for MPF activation are less understood, although they seem to proceed in two steps, both in amphibians and the starfish. The first step, in which a small amount of MPF is produced, is independent of transcription of the oocyte genome (43) (44) (45) . In both forms, this step might depend on the activation of endogenous proteases since it is blocked by various protease inhibitors that are ineffective once MPF has appeared (46) (47) (48) . In the amphibian (49), but not in the starfish (44) , MPF requires the synthesis of a protein initiator. The subsequent autocatalytic amplification step, which is best studied in serial transfer experiments (49-51), does not depend on protein synthesis (6, 51, 52) but involves some participation of the GV nucleoplasm (53) .
In this study, we used the polyethylene glycol (PEG) procedure (54) treated with the hormone 1-methyladenine at 1 AuM to induce maturation. Jelly coat and vitelline envelope were simultaneously removed by gently swirling the samples for 18 min in calcium-free artificial sea water (Ca-free ASW) containing 0.05% Pronase. Washed oocytes were stored until use or immediately transferred to a Petri dish containing 20-30 ml of Ca-free ASW. Under these conditions, fusion could be induced in <25 min after hormone addition-i.e., 7 min after the beginning of GVBD and 45 min and 95 min before extrusion of the first or second polar body, respectively. Maturation of follicle-free oocytes was also induced by shaking (56) , increase of external calcium concentration (57), addition of arachidonic acid (58), or ionic stress resulting from pulse incubation of the follicle-free oocytes in isoosmotic urea/Ca-free ASW (1:1).
Cell Fusion. A drop of a viscous (50%) PEG solution, made in Ca-free ASW (wt/wt), was laid down in the center of the Petri dish and the oocytes were gently swirled to its top. After 2-4 min, the oocyte aggregates were dissociated by increasing the rotation rate, which dispersed the population toward fresh Ca-free sea water. Fused pairs were collected immediately for observation. Control microinjections were performed following the technique of Hiramoto (59, 60) .
Chemicals. PEG (Mr 6000) was obtained from Serva (Heidelberg); chymostatin was a gift of T. Aoyagi (Institute of Microbial Chemistry, Tokyo). Diamide, emetine, leupeptin, 1-methyladenine, N-benzoyl-L-tyrosine ethyl ester (BTEE), p-tosyl-L-arginine methyl ester (TAME), and soybean trypsin inhibitor (SBTI) were from Sigma. Stock solutions were prepared in Ca-free ASW, except for chymostatin and BTEE, which were dissolved in dimethyl sulfoxide (Me2SO) and diluted at least 1:100 in the assay; this vehicle had no effect on maturation at this concentration.
RESULTS
Fate of the Homologous Pairs. Sixty-six GV-GV pairs and 51 ootid-ootid (0-0) pairs were followed for long periods of time, usually >8 hr. In no case did spontaneous breakdown of the GV or the pronuclear envelope occur ( Fig. 1 A and B) . These composite oocytes responded normally to 100 ,uM 1-methyladenine, which induced maturation-i.e., GVBD 11 ootids. These did not change for more than 2-4 hr, at which time, some injected and uninjected companion ootids exhibited the cortical reaction and broke down their pronucleus. In contrast, control microinjections using 9 GV-arrested oocytes as recipient produced 100% GVBD in <20 min. In another set of experiments, we also verified that 100 ,uM 1-methyladenine, 10 .M ionophore A23187, and hypertony (100 mM excess KCl) produced ootid activation within 1 hr. Pronuclear breakdown but not cortical reaction was inhibited following a 30-min preincubation in 0.9 mM emetine, a treatment that had no effect on 1-methyladenineinduced GVBD (44) . Instead, activation was not impaired after preincubating the ootids in the presence of 0.2 mM BTEE or chymostatin or leupeptin at 1 mg/ml, which usually block hormone-induced maturation (47, 48) .
Fate of the Heterologous (GV-O) Pairs. Fifty-six GV-O pairs were prepared at times ranging from 1 to 8 hr after second polar body extrusion had occurred in the ootid partners (Fig. 1C) . Except for the arachidonic acid pairs, which were blocked for >2 hr and did not show GVBD upon subsequent addition of 100 tkM 1-methyladenine, all of the remaining 45 pairs evolved normally up to the second meiotic cleavage. In these pairs, the female pronucleus first disappeared, 3-5 min before GVBD, which took place about 40 min after PEG-induced fusion (Table 1 and Fig. 1 D and E) body was expelled 55-60 min later and the fused oocyte system presented two pronuclei. Sometimes, however, polar body extrusion failed to occur and two pronuclei were formed from the original GV partner (Fig. 1F) . The observed time schedule for these events corresponded exactly to that observed following 1-methyladenine stimulation, except that GVBD was delayed by about 20 min. Effect of Nicotinamide. Nicotinamide, which has been reported to block MPF action since it inhibits 1-methyladenine-and MPF-induced maturation (61), also blocks development of the fused oocytes (20 pairs) for >2-5 hr. However, the fused oocytes were not irreversibly affected by this treatment since they developed normally after washing and treating them with 100 AtM 1-methyladenine ( Table 2) .
Effect of Diamide. Eleven of 13 fused (GV-O) pairs, preincubated for >40 min in 0.2 mM diamide, a drug that was found to inhibit protein phosphorylation and GVBD in hormone-stimulated oocytes (27) and to block maturation of mechanically GV-disrupted oocytes (58), failed to develop. Shorter treatments (4 pairs) were found to be ineffective ( Table 2) .
Effect of Protease Inhibitors. SBTI, which is not supposed to penetrate the oocytes due to its molecular weight (Mr 21,000), was unable to change the timing of maturation in the 13 GV-O pairs tested. TAME, a synthetic substrate for trypsin, also proved to be a rather poor inhibitor; it was only effective (18/25 pairs) after long incubation periods, when maturation was highly delayed or blocked irreversibly (Table  2) . Instead, BTEE, a synthetic substrate for chymotrypsin, was already active at a lower concentration (by a factor of 10) and for shorter incubation periods (Table 2) . Finally, chymostatin, an inhibitor of chymotrypsin-like proteases and some thiol proteases (62) , was also effective in delaying maturation in the 10 GV-O pairs that were incubated in this drug just before starting the fusion.
Effect of Emetine. Emetine, an inhibitor of polypeptide chain elongation, suppresses almost instantaneously protein synthesis in starfish oocytes without affecting GVBD (44) or MPF amplification (52) . When applied to GV-O pairs, it greatly delayed GVBD and eventually blocked it irreversibly (Table 2 ). In contrast, GVBD occurred within 20-30 min in control GV-GV pairs treated for the same period, first with emetine and then with 100 ,M 1-methyladenine.
DISCUSSION
Our data indicate that oocytes induced to reinitiate meiosis by arachidonic acid, shaking, ionic stress, or increased external calcium, in the absence of hormone treatment, form active MPF since they trigger maturation when fused with GV-blocked oocytes. This demonstrates clearly that true MPF is formed under these various conditions, in agreement with the fact that microinjection of nucleoplasm from GVarrested oocytes may produce transferable levels of MPF (63) .
Our data also show that MPF from a maturing oocyte may trigger breakdown of the female pronucleus in the ootid partner, which, on the other hand, is devoid of amplification capacity.
Finally, our data demonstrate that fusion between an immature GV-blocked oocyte, which contains only unactivated latent MPF and protein kinases, and a female pronucleus-blocked oocyte devoid ofmicroinjection-transferable activity restores the capacity of the system to produce active MPF. This conclusion, which argues for the existence of a metabolic cooperation process, by which the ootid partner would activate latent MPF precursor molecules in the GV partner, would be valid only if the ootid partners were actually devoid of MPF. Such an assumption, which could not be easily obtained through microinjection experiments that transfer too small a volume of donor cytoplasm (16) , is now supported by the following observations: (i) homologous 0-0 fusions are always ineffective, whereas fusion with a maturing oocyte induces breakdown ofthe female pronucleus envelope; (ii) the time required for GVBD appears twice as long after fusion than after hormone addition-i.e., 38 min instead of 18 min; (iii) emetine, which does not affect MPF amplification (52) , delays development of the fused heterologous pairs; (iv) the formation of two nuclei, one in each partner, after first polar body extrusion, indicates that fewer potential MPF molecules may be present at this specific stage than after hormone stimulation, where there is no pronuclear reconstitution.
That such a metabolic cooperation results in true MPF formation is shown not only by nuclear envelope disruption of the female pronucleus (which occurs first) and the GV but also by the fact it is reversibly inhibited by nicotinamide, which is known to interfere with MPF action but not MPF formation (59) . It is highly probable that MPF activation involves endogenous protein phosphorylation since it is blocked by diamide, which suppresses phosphorylation and GVBD in hormone-stimulated oocytes (27) and inhibits maturation of mechanically GV-disrupted oocytes (56) . However, it cannot be excluded that this SH-oxidizing agent (64) may act at an intermediate step in MPF activation, which may involve proteases.
An alternative possibility would be that the GV partner provides the system with unactivated MPF precursor molecules as well as with the amplification system since this one is obviously absent in the ootid partner that cannot amplify its putative vestigial MPF. This interpretation would only stress the superiority of the fusion over the microinjection technique. However, our results indicate that such an amplification now requires a consistent level of protein synthesis, which is not the case when microinjection is performed from a maturing to a GV-arrested oocyte (52) . In addition, except for SBTI, which cannot penetrate the plasma membrane, all of the protease inhibitors or substrates tested were found to be inhibitory, as first described for hormonestimulated oocytes, where they inhibit MPF formation but not MPF amplification and function (47, 48) . In both cases, chymotrypsin inhibitors were found to be more efficient than trypsin inhibitors. It is worth noting that intracellular microinjection of two trypsin inhibitors, SBTI and leupeptine, has been reported to protect MPF against degradation at the time of polar body extrusion (16) . It thus seems likely that MPF activation and inactivation may be regulated by endogenous proteases. Presently, however, we lack adequate criteria for characterizing them.
Our data suggest, as the timing observed for maturation, that the threshold MPF level required to obtain nuclear envelope breakdown cannot be reached from the GV partner alone and that amplification in the fused pair may be controlled by the same protein factors that are involved after first polar body extrusion (16) or activation. This may indicate that MPF-inactivating proteases or a pronuclear state stabilizing factor were always present in the ootid partner, which are only destroyed following activation or synthesis of an antagonistic protein factor. One may also consider that such proteases have destroyed MPF precursor molecules in the pair, while they (or other proteases, possibly chymotrypsin-like proteases) simultaneously directly activate nascent MPF or protein kinases molecules, which, in this state, might be protected against degradation. This would account for the lag introduced before GVBD and for the fact that emetine-treated GV-GV pairs recover more easily following hormone stimulation than corresponding GV-O pairs.
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